OncoVista Innovative Therapies (OncoVista Innovative Therapies) Effective Interest Rate on Debt % : 8.09% (As of Sep. 2015)

View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. OncoVista Innovative Therapies's annualized positive value of Interest Expense for the quarter that ended in Sep. 2015 was $0.04 Mil. OncoVista Innovative Therapies's average total debt for the quarter that ended in Sep. 2015 was $0.45 Mil. Therefore, OncoVista Innovative Therapies's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2015 was 8.09%.

OncoVista Innovative Therapies Effective Interest Rate on Debt % Historical Data

The historical data trend for OncoVista Innovative Therapies's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies Effective Interest Rate on Debt % Chart

OncoVista Innovative Therapies Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

3.62

15.38

4.17

3.85

OncoVista Innovative Therapies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															7.84	7.77	7.53	8.72	8.09

Competitive Comparison of OncoVista Innovative Therapies's Effective Interest Rate on Debt %

For the Biotechnology subindustry, OncoVista Innovative Therapies's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's Effective Interest Rate on Debt % falls into.

OncoVista Innovative Therapies Effective Interest Rate on Debt % Calculation

OncoVista Innovative Therapies's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2014 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2013 )	+	Total Debt (A: Dec. 2014 ))	/ count )
=	-1 * -0.008	/	( (0	+	0.208)	/ 1 )
=	-1 * -0.008	/	0.208
=	3.85 %

where

	Total Debt (A: Dec. 2013 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

	Total Debt (A: Dec. 2014 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.208
=	0.208

OncoVista Innovative Therapies's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2015 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2015 )	+	Total Debt (Q: Sep. 2015 ))	/ count )
=	-1 * -0.036	/	( (0.411	+	0.479)	/ 2 )
=	-1 * -0.036	/	0.445
=	8.09 %

where

	Total Debt (Q: Jun. 2015 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.411
=	0.411

	Total Debt (Q: Sep. 2015 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.479
=	0.479

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2015) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

OncoVista Innovative Therapies (OTCPK:OVIT) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

OncoVista Innovative Therapies Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245

Website

http://www.oncovista.com

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

Executives

Alexander Ruckdaeschel	director	123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal	director	C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp	10 percent owner	777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs	10 percent owner	C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd	10 percent owner	411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Headlines

No Headlines